Myrtelle Announces Presentation of Positive 12-month Post Treatment Data in its First-in-Human Clinical Study of rAAV-Olig001-ASPA Gene Therapy at the 2023 Cell & Gene Meeting on the Mesa held by the Alliance for Regenerative Medicine
Wakefield, Mass., October 10, 2023 – Myrtelle Inc. (“Myrtelle” or the “Company”), a gene therapy company focused on developing transformative treatments for neurodegenerative diseases…
Article Date
October 10, 2023
This article is featured on another website.
Go to article
January 26, 2026
Leveraging China to Maximize Global Study Impact
China's healthcare market is expanding rapidly due to urbanization, with a population of about 1.4…
January 26, 2026
Leveraging China to Maximize Global Study Impact
China's healthcare market is expanding rapidly due to urbanization, with a population of about 1.4…